Mirum Pharmaceuticals (MIRM) Total Current Liabilities (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Total Current Liabilities of $272.8 million for Q1 2026, up 113.85% year-over-year from $127.6 million in Q1 2025, and up 32.57% quarter-over-quarter from $205.8 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Total Current Liabilities (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $272.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 113.85% year-over-year to $272.8 million; the TTM figure through Mar 2026 stood at $272.8 million (up 113.85% YoY), while the FY2025 annual figure was $205.8 million, up 62.62% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $272.8 million, up from $205.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $272.8 million in Q1 2026, with the low at $34.6 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $105.9 million (2024), against an average of $108.0 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities fell 1.34% in 2022, then surged 116.84% in 2024.
- Mirum Pharmaceuticals' Total Current Liabilities stood at $64.7 million in 2022, then jumped by 34.51% to $87.1 million in 2023, then surged by 45.35% to $126.6 million in 2024, then surged by 62.62% to $205.8 million in 2025, then surged by 32.57% to $272.8 million in 2026.
- Business Quant data shows MIRM's Total Current Liabilities at $272.8 million in Q1 2026, $205.8 million in Q4 2025, and $160.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.79 Mn |
| Mar 31, 2026 | 272.82 Mn |
| Dec 31, 2025 | 205.80 Mn |
| Sep 30, 2025 | 160.36 Mn |
| Jun 30, 2025 | 144.80 Mn |
| Mar 31, 2025 | 127.58 Mn |
| Dec 31, 2024 | 126.55 Mn |
| Sep 30, 2024 | 115.75 Mn |
| Jun 30, 2024 | 112.31 Mn |
| Mar 31, 2024 | 105.91 Mn |
| Dec 31, 2023 | 87.06 Mn |
| Sep 30, 2023 | 74.66 Mn |
| Jun 30, 2023 | 58.20 Mn |
| Mar 31, 2023 | 48.84 Mn |
| Dec 31, 2022 | 64.73 Mn |
| Sep 30, 2022 | 51.40 Mn |
| Jun 30, 2022 | 45.17 Mn |
| Mar 31, 2022 | 34.55 Mn |
| Dec 31, 2021 | 42.60 Mn |
| Sep 30, 2021 | 50.39 Mn |